Zdrowie i gospodarka · 14/07/1998
FDA Releases Guidance on 180-Day Generic Drug Exclusivity Under Hatch-Waxman Act
The FDA has announced the availability of a guidance document outlining its application of the 180-day generic drug exclusivity provisions of the Federal Food, Drug, and Cosmetic Act following recent court decisions.